Specifically, this strategy simultaneously inhibits iNOS/NO-mediated anti-apoptotic signals and pro-invasive signaling in directly targeted tumor cells, while also impeding the proliferation and migration of adjacent non-irradiated cells that are influenced by NO diffusion. Here, NOS2 is linked to neoplasm.